These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17116649)

  • 1. Estimating lifetime risk of developing high serum total cholesterol: adjustment for baseline prevalence and single-occasion measurements.
    Pencina MJ; D'Agostino RB; Beiser AS; Cobain MR; Vasan RS
    Am J Epidemiol; 2007 Feb; 165(4):464-72. PubMed ID: 17116649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifetime risk for developing dyslipidemia: the Framingham Offspring Study.
    Cobain MR; Pencina MJ; D'Agostino RB; Vasan RS
    Am J Med; 2007 Jul; 120(7):623-30. PubMed ID: 17602937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum total cholesterol--an indicator for monitoring cholesterol lowering efforts: U.S. adults, 2005-2006.
    Schober SE; Carroll MD; Lacher DA; Hirsch R;
    NCHS Data Brief; 2007 Dec; (2):1-8. PubMed ID: 19389314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of past and recent blood pressure and cholesterol level on coronary heart disease and stroke mortality, accounting for measurement error.
    Boshuizen HC; Lanti M; Menotti A; Moschandreas J; Tolonen H; Nissinen A; Nedeljkovic S; Kafatos A; Kromhout D
    Am J Epidemiol; 2007 Feb; 165(4):398-409. PubMed ID: 17116650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring and treating serum lipids in patients in a chest pain observation unit.
    Gillespie MJ; Davis CJ; Lambert ND; Costello FM; Smith SC; Cohen MG; Menon V
    Am J Cardiol; 2007 Jun; 99(12):1718-20. PubMed ID: 17560881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002.
    Keevil JG; Cullen MW; Gangnon R; McBride PE; Stein JH
    Circulation; 2007 Mar; 115(11):1363-70. PubMed ID: 17353444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.
    Skoumas I; Masoura C; Pitsavos C; Tousoulis D; Papadimitriou L; Aznaouridis K; Chrysohoou C; Giotsas N; Toutouza M; Tentolouris C; Antoniades C; Stefanadis C
    Int J Cardiol; 2007 Oct; 121(2):178-83. PubMed ID: 17188767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hypercholesterolemia in a national worksite sample.
    Wilson MG; Edmunson J
    Am J Prev Med; 1991; 7(5):280-4. PubMed ID: 1790033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National improvements in low-density lipoprotein cholesterol management of individuals at high coronary risk: National Health and Nutrition Examination Survey, 1999 to 2002.
    Cullen MW; Stein JH; Gangnon R; McBride PE; Keevil JG
    Am Heart J; 2008 Aug; 156(2):284-91. PubMed ID: 18657658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipid control in diabetic patients in Extremadura (Spain)].
    Roberto Robles N; Barroso S; Marcos G; Sánchez Muñoz-Torrero JF;
    Endocrinol Nutr; 2009 Mar; 56(3):112-7. PubMed ID: 19627723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercholesterolemia treatment patterns and low-density lipoprotein cholesterol monitoring in patients with a diagnosis of atherosclerosis in clinical practice.
    Davidson MH; Gandhi SK; Ohsfeldt RL; Fox KM
    Am J Med; 2009 Jan; 122(1 Suppl):S51-9. PubMed ID: 19110088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of coronary artery disease and coronary risk factors in an urban population of Tirupati.
    Latheef SA; Subramanyam G
    Indian Heart J; 2007; 59(2):157-64. PubMed ID: 19122250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors of hypercholesterolemia among Thai men and women receiving health examinations.
    Le D; Garcia A; Lohsoonthorn V; Williams MA
    Southeast Asian J Trop Med Public Health; 2006 Sep; 37(5):1005-14. PubMed ID: 17333747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lowering LDL cholesterol in adults: a prospective, community-based practice initiative.
    Coodley GO; Jorgensen M; Kirschenbaum J; Sparks C; Zeigler L; Albertson BD
    Am J Med; 2008 Jul; 121(7):604-10. PubMed ID: 18538295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the impact of adding C-reactive protein as a criterion for lipid lowering treatment in the United States.
    Woloshin S; Schwartz LM; Kerin K; Welch HG
    J Gen Intern Med; 2007 Feb; 22(2):197-204. PubMed ID: 17356986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults, 1971-2002.
    Kanjilal S; Gregg EW; Cheng YJ; Zhang P; Nelson DE; Mensah G; Beckles GL
    Arch Intern Med; 2006 Nov; 166(21):2348-55. PubMed ID: 17130388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey.
    Onat A; Hergenç G; Uyarel H; Can G; Ozhan H
    Anadolu Kardiyol Derg; 2006 Dec; 6(4):314-21. PubMed ID: 17162275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data.
    Bieler GS; Brown GG; Williams RL; Brogan DJ
    Am J Epidemiol; 2010 Mar; 171(5):618-23. PubMed ID: 20133516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.